[PDF][PDF] TOWARDS DEFINING THE ENDOMEMBRANE COMPARTMENTS OPERATING IN CELLULAR EXIT OF CORONVIRUSES

M Enyioko - 2021 - bora.uib.no
… into its amino terminal S1 subunit and carboxyl terminal S2 subunit. S1 enables the virus to
… compartment during its delivery to the PM [71]. The Drosophila α-integrin again has been …

[PDF][PDF] The effects of a combination of two receptor tyrosine kinase inhibitors on two ovarian cancer cell lines.

WNH Al-Hussainni - 2017 - ir.canterbury.ac.nz
… The concentration dependence of canertinib and PHA665752 in the presence of fetal
bovine serum (FBS) or growth factors ..................................................................................... 90 3.3.3.1 …

[PDF][PDF] Investigating the control of macrophage function by clearance of apoptotic cells using Drosophila melanogaster

HG Roddie - 2018 - etheses.whiterose.ac.uk
… This study also shows that the α integrin subunits αPS1 and αPS3 (Scab) are required for …
13, and that this migration is delayed in mutants for these subunits (Comber et al. 2013). In this …

Non-enzymatic roles of kinases and phosphatases-the case of MTMR9 and AAK1

F Knop - 2024 - dspace.cuni.cz
… Interestingly, whereas SEL-5 does seem to phosphorylate the AP2 complex µ2 subunit,
we … We decided to first analyse in detail the subcellular distribution of MTMR9. We tested …

Diindolylmethane Analogs as Novel NR4A1 Antagonists and as a Novel Class of Anticancer Agents and Sp Transcription Factors as Nononcogene Addiction Genes …

ED Hedrick - 2016 - oaktrust.library.tamu.edu
… The first class is the canonical class most implicated in cancer and is composed of two
subunits a p110 catalytic subunit and a p85 catalytic subunit (79,80). The catalytic subunit

Chemical advances in therapeutic application of exosomes and liposomes

BC Chew, FF Liew, HW Tan… - Current medicinal …, 2022 - ingentaconnect.com
… The chemical similarities between naturally occurring exosomes and synthetic liposomes
have accelerated the development of exosome mimetics as a therapeutic drug delivery